Administration of BMSCs with muscone in rats with gentamicin-induced AKI improves their therapeutic efficacy

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Liu, Pengfei ^a,b   Feng, Yetong ^a,b   Dong, Chao ^a   Yang, Dandan ^a,b   Li, Bo ^a,b   Chen, Xin ^c   Zhang, Zhongjun ^c   Wang, Yi ^a   Zhou, Yulai ^a   Zhao, Lei ^c  

^a JILIN UNIVERSITY   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^c SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL3 CHEMOKINE; GENTAMICIN; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; MUSCONE; RANTES; CHEMOKINE RECEPTOR CXCR; CMKOR1 PROTEIN, RAT; CXCR4 PROTEIN, RAT; CYCLOALKANE DERIVATIVE; PRIMER DNA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY MASS; KIDNEY TUBULE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANIMAL; CELL MOTION; CHEMICALLY INDUCED; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NICK END LABELING; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL5; CYCLOPARAFFINS; DNA PRIMERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GENTAMICINS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR; RECEPTORS, CXCR4;

EID: 84901285360     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097123     Document Type: Article

References (65)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370. (Pubitemid 46179340)
2. Bagshaw SM (2008) Short- and long-term survival after acute kidney injury. Nephrol Dial Transplant 23: 2126-2128.
3. Kellum JA, Hoste EA (2008) Acute kidney injury: epidemiology and assessment. Scand J Clin Lab Invest Suppl 241: 6-11. (Pubitemid 351883670)
4. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. American Journal of Kidney Diseases 39: 930-936. (Pubitemid 34454211)
5. Bellomo R,Kellum JA, RoncoC (2012) Acute kidney injury. Lancet 380: 756-766.
6. Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221.
7. Wang L, Zhao S, Mao H, Zhou L, Wang ZJ, et al. (2011) Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus. Chin Med J (Engl) 124: 3622-3628.
8. Kanno H (2013) Regenerative therapy for neuronal diseases with transplantation of somatic stem cells. World J Stem Cells 5: 163-171.
9. Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10: 740-749.
10. Bilousova G, Roop DR (2013) Generation of functional multipotent keratinocytes from mouse induced pluripotent stem cells. Methods Mol Biol 961: 337-350.
11. Li T, Zhu J, Ma K, Liu N, Feng K, et al. (2013) Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats. J Surg Res 184: 1161-1173.
12. Fujimoto Y, Abematsu M, Falk A, Tsujimura K, Sanosaka T, et al. (2012) Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 30: 1163-1173.
13. Raja N, Miller WE, McMillan R, Mason JR (1998) Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue. Bone Marrow Transplant 21: 1283-1284. (Pubitemid 28318760)
14. Togel F, Hu ZM, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology-Renal Physiology 289: F31-F42. (Pubitemid 40863570)
15. Iwasaki M, Adachi Y, Minamino K, Suzuki Y, Zhang Y, et al. (2005) Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 16: 658-666. (Pubitemid 41725102)
16. Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, et al. (2012) Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 21: 1911-1923.
17. Li L, Black R, Ma Z, Yang Q, Wang A, et al. (2012) Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury. Am J Physiol Renal Physiol 302: F9-F19.
18. Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, et al. (2014) Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS One 9: e87853.
19. Liu N, Tian J, Cheng J, Zhang J (2013) Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment. Exp Cell Res 319: 2019-2027.
20. Reis LA, Borges FT, Simoes MJ, Borges AA, Sinigaglia-Coimbra R, et al. (2012) Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 7: e44092.
21. Qi S, Wu D (2013) Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med 32: 1262-1272.
22. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, et al. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395. (Pubitemid 41671625)
23. Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, et al. (2011) Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol 300: F254-262.
24. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, et al. (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26: 1474-1483.
25. Jia X, Xie X, Feng G, Lu H, Zhao Q, et al. (2012) Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury. BMC Nephrol 13: 105.
26. Eliopoulos N, Zhao J, Forner K, Birman E, Young YK, et al. (2011) Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice. Mol Ther 19: 2072-2083.
27. Liu N, Tian J, Cheng J, Zhang J (2013) Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney. J Cell Biochem 114: 2677-2689.
28. Gheisari Y, Azadmanesh K, Ahmadbeigi N, Nassiri SM, Golestaneh AF, et al. (2012) Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury. Stem Cells Dev 21: 2969-2980.
29. Lin DL, Chang HC, Huang SH (2004) Characterization of allegedly musk-containing medicinal products in Taiwan. J Forensic Sci 49: 1187-1193.
30. Wu Q, Li H, Wu Y, ShenW, Zeng L, et al. (2011) Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes. J Ethnopharmacol 138: 34-39.
31. Ford RA, Api AM, Newberne PM (1990) 90-day dermal toxicity study and neurotoxicity evaluation of nitromusks in the albino rat. Food Chem Toxicol 28: 55-61. (Pubitemid 20087097)
32. Xie XW, Hou FW, Li N (2012) Effects of musk ketone at different concentrations on in vivo migration of exogenous rat bone marrow mesenchymal stem cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 980-985.
33. Xinaris C, Morigi M, Benedetti V, Imberti B, Fabricio AS, et al. (2013) A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant 22: 423-436.
34. Liu P, Feng Y, Dong C, Liu D, Wu X, et al. (2013) Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in rats. Life Sci 92: 829-837.
35. Cheng K, Rai P, Plagov A, Lan X, Kumar D, et al. (2013) Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol 94: 466-473.
36. Hanf W, Guillaume C, Jolivot A, Chapuis-Cellier C, Guebre-Egziabher F, et al. (2010) Prolonged hemodialysis for acute kidney injury in myeloma patients. Clin Nephrol 74: 319-322.
37. Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, et al. (2010) Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy. Ther Apher Dial 14: 451-456.
38. Shi SF, Zhou FD, Zou WZ, Wang HY (2012) Acute kidney injury and bilateral symmetrical enlargement of the kidneys as first presentation of B-cell lymphoblastic lymphoma. Am J Kidney Dis 60: 1044-1048.
39. Wadhwa NK, Kamra A, Skopicki HA, Richard S, Miller F, et al. (2012) Reversible left ventricular dysfunction and acute kidney injury in a patient with nonamyloid light chain deposition disease. Clin Nephrol 78: 501-505.
40. Johannes T, Mik EG, Klingel K, Dieterich HJ, Unertl KE, et al. (2009) Low-dose dexamethasone-supplemented fluid resuscitation reverses endotoxin-induced acute renal failure and prevents cortical microvascular hypoxia. Shock 31: 521-528.
41. Kumar S, Allen DA, Kieswich JE, Patel NS, Harwood S, et al. (2009) Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol 20: 2412-2425.
42. Lee AK, Lee JH, Kwon JW, Kim WB, Kim SG, et al. (2004) Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate. Biopharm Drug Dispos 25: 273-282. (Pubitemid 39294806)
43. Sun QL, Chen YP, Rui HL (2010) Establishment of a new rat model of chronic cyclosporine A nephrotoxicity. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 32: 205-209.
44. Yu S, Yu L (2012) Dexamethasone Resisted Podocyte Injury via Stabilizing TRPC6 Expression and Distribution. Evid Based Complement Alternat Med 2012: 652059.
45. Zhou L, Yao X, Chen Y (2012) Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion. Inflammation 35: 289-296.
46. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, et al. (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24: 1030-1041. (Pubitemid 44464736)
47. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J (2008) Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 3: e2934.
48. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-848.
49. Herberg S, Shi X, Johnson MH, Hamrick MW, Isales CM, et al. (2013) Stromal cell-derived factor-1beta mediates cell survival through enhancing autophagy in bone marrow-derived mesenchymal stem cells. PLoS One 8: e58207.
50. Ahmadbeigi N, Seyedjafari E, Gheisari Y, Atashi A, Omidkhoda A, et al. (2010) Surface expression of CXCR4 in unrestricted somatic stem cells and its regulation by growth factors. Cell Biol Int 34: 687-692.
51. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, et al. (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766. (Pubitemid 41532769)
52. Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, et al. (2008) Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 205: 479-490. (Pubitemid 351281611)
53. Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, et al. (2008) In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 105: 20641-20646.
54. Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, et al. (2010) Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177: 2011-2021.
55. Paller MS, Hoidal JR, Ferris TF (1984) Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74: 1156-1164. (Pubitemid 15206810)
56. Ebenezer PJ, Mariappan N, Elks CM, Haque M, Soltani Z, et al. (2009) Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats. Life Sci 85: 357-364.
57. Cai J, Zhang Y, Liu P, Chen S, Wu X, et al. (2013) Generation of tooth-like structures from integration-free human urine induced pluripotent stem cells. Cell Regeneration 2: 6.
58. Yamada Y, Watanabe Y, Zhang J, Haraoka J, Ito H (2002) Changes in cortical and cerebellar bcl-2 mRNA levels in the developing hydrocephalic rat (LEWHYR) as measured by a real time quantified RT-PCR. Neuroscience 114: 165-171. (Pubitemid 35247498)
59. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, et al. (2011) Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 18: 22.
60. Lipfert J, Odemis V, Wagner DC, Boltze J, Engele J (2013) CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia. Neuropathol Appl Neurobiol 39: 667-680.
61. Krzysiek-Maczka G, Targosz A, Ptak-Belowska A, Korbut E, Szczyrk U, et al. (2013) Molecular alterations in fibroblasts exposed to Helicobacter pylori: a missing link in bacterial inflammation progressing into gastric carcinogenesis? J Physiol Pharmacol 64: 77-87.
62. Smirkin A, Matsumoto H, Takahashi H, Inoue A, Tagawa M, et al. (2010) Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 30: 603-615.
63. Luo Z, Liu H, Sun X, Guo R, Cui R, et al. (2013) RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats. PLoS One 8: e55860.
64. Zhang Z, Zhong W, Hall MJ, Kurre P, Spencer D, et al. (2009) CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis. Exp Eye Res 89: 522-531.
65. Kolambkar YM, Bajin M, Wojtowicz A, Hutmacher DW, Garcia AJ, et al. (2014) Nanofiber orientation and surface functionalization modulate human mesenchymal stem cell behavior in vitro. Tissue Eng Part A 20: 398-409.